Advertisement
Australia markets close in 1 hour 35 minutes
  • ALL ORDS

    7,994.80
    -1.70 (-0.02%)
     
  • ASX 200

    7,733.20
    -2.60 (-0.03%)
     
  • AUD/USD

    0.6505
    -0.0008 (-0.12%)
     
  • OIL

    78.49
    -0.25 (-0.32%)
     
  • GOLD

    2,121.50
    -4.80 (-0.23%)
     
  • Bitcoin AUD

    104,709.98
    +7,004.41 (+7.17%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • AUD/EUR

    0.5992
    -0.0002 (-0.03%)
     
  • AUD/NZD

    1.0674
    -0.0002 (-0.02%)
     
  • NZX 50

    11,746.31
    +22.11 (+0.19%)
     
  • NASDAQ

    18,226.48
    -76.42 (-0.42%)
     
  • FTSE

    7,640.33
    -42.17 (-0.55%)
     
  • Dow Jones

    38,989.83
    -97.57 (-0.25%)
     
  • DAX

    17,716.17
    -18.93 (-0.11%)
     
  • Hang Seng

    16,222.11
    -373.86 (-2.25%)
     
  • NIKKEI 225

    39,940.61
    +29.81 (+0.07%)
     

AbbVie Just Announced 2 Big Acquisitions: Is This Dividend King a No-Brainer Buy Right Now?

AbbVie Just Announced 2 Big Acquisitions: Is This Dividend King a No-Brainer Buy Right Now?

AbbVie's share price reflected the concerns. AbbVie's executives and business development team have been quite busy lately. On Nov. 30, AbbVie announced its plans to acquire ImmunoGen (NASDAQ: IMGN) in an all-cash transaction valued at roughly $10.1 billion.